Afinitor (everolimus) Tablets
Afinitor is a kinase inhibitor used for the treatment of adults with progressive neuroendocrine tumors of pancreatic origin and adults with progressive, well-differentiated, nonfunctional neuroendocrine tumors (NETs) of gastrointestinal or lung origin that are unresectable, locally advanced, or metastatic.
Novartis’ Patient Assistance NOW Oncology offers 2 financial assistance programs for patients using Afinitor:
Novartis Oncology Universal Co-pay Program
Through this program, patients with private insurance will be responsible for up to $25 monthly in copay and co-insurance for Afinitor. The program pays the remaining balance until a yearly maximum of $15,000 is met.
Novartis Patient Assistance Foundation
To be eligible for financial assistance through this program, patients without insurance must be US citizens and must provide proof of income that meets the financial eligibility requirements. Eligible patients may receive Afinitor for free until prescription drug coverage becomes available to them.
Lutathera (lutetium Lu 177 dotatate)
Lutathera is a radiolabeled somatostatin analog used for the treatment of adults with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (NETs), including foregut, midgut, and hindgut NETs.
AAA PatientCONNECT offers 2 financial assistance programs for patients who have been prescribed Lutathera:
AAA PatientCONNECT Copay Assistance Program
For eligible patients who have private insurance, this program provides up to $15,000 annually, so that patients pay no more than $25 per an infusion of Lutathera.
AAA PatientCONNECT Patient Assistance Program
Through this program, eligible patients who have no health insurance to cover their medication will receive help to cover their cost of Lutathera.
Somatuline Depot (lanreotide) Injection
Somatuline Depot is a somatostatin analog used for the treatment of patients with unresectable, well-differentiated or moderately differentiated, locally advanced or metastatic neuroendocrine tumors (NETs) of gastrointestinal or pancreatic origin.
Ipsen Cares offers 2 financial assistance programs for patients using Somatuline Depot:
Somatuline Depot Virtual Copay Savings Program
Eligible patients with private insurance pay no more than $5 per prescription with this program for 12 months, 13 injections, or for a maximum copay benefit of $20,000 (whichever comes first). Patients with no insurance, or those whose insurance does not cover Somatuline Depot, may pay more than $5 per prescription and their maximum copay benefit amount for prescriptions is $1,666.66, up to an annual maximum of $20,000.
Somatuline Depot Patient Assistance Program
Eligible patients who are experiencing financial hardship, or who have no insurance coverage, and meet specific medical criteria will receive Somatuline Depot for free.
Sutent (sunitinib malate) Capsules
Sutent is a kinase inhibitor used for the treatment of patients with locally advanced or metastatic pancreatic neuroendocrine tumors (NETs) that have progressed and cannot be removed by surgery.
Pfizer Oncology Together offers 2 financial assistance programs for patients using Sutent:
Pfizer Oncology Together Co-Pay Savings Program
This Pfizer program assists eligible patients with private insurance so that their copay for Sutent is $0 monthly, with a maximum savings of up to $25,000 annually.
Pfizer Patient Assistance Program
This program serves patients who are either uninsured or those with government insurance. Uninsured patients may qualify to receive Sutent for free or at a savings. Eligible patients with government insurance, who cannot find independent charitable foundation support, may receive Sutent for free.
Welireg (belzutifan) Tablets
Welireg is a hypoxia-inducible factor inhibitor used for the treatment of adults with von Hippel-Lindau disease and pancreatic neuroendocrine tumors (NETs) not requiring immediate surgery.
Merck Access Program offers 2 financial assistance programs for patients using Welireg:
Merck Co-Pay Coupon
Eligible patients who have private insurance may pay as little as $5 for the first out-of-pocket cost of Welireg, with a maximum program savings of up to $8,700 per patient. The coupon is valid for up to a 90-day supply per prescription fill, and may be redeemed only once every 21 days.
Merck Patient Assistance Program
Uninsured or underinsured patients may receive Welireg for free through this program. Eligible patients must have a household income of $64,400 or less for individuals, $87,100 or less for couples, or $132,000 or less for a family of 4.
Table. Drugs Prescribed for Neuroendocrine Tumors (NETs)
- Drug name (generic name)
- Drug company
- Indications
- Patient support services
- Afinitor (everolimus) Tablets
- Novartis
- Treatment of adults
with progressive neuroendocrine
tumors (NETs)
of pancreatic origin
Treatment of adults with progressive, well-differentiated, nonfunctional NETs of gastrointestinal or lung origin that are unresectable, locally advanced, or metastatic - Novartis Oncology Universal Co-pay Program
877-577-7756
Novartis Patient Assistance Foundation
800-277-2254
- Lutathera (lutetium Lu 177 dotatate)
- Advanced Accelerator Application
- Treatment of somatostatin receptor-positive gastroenteropancreatic NETs, including foregut, midgut, and hindgut NETs
- AAA PatientCONNECT Copay Assistance Program
844-638-7222
AAA PatientCONNECT Patient Assistance Program
844-638-7222
- Somatuline Depot (lanreotide) Injection
- Ipsen
- Unresectable, welldifferentiated or moderately differentiated, locally advanced or metastatic NETs of gastrointestinal tract or pancreas origin
- Somatuline Depot Virtual Copay Savings Program
866-435-5677
Somatuline Depot Patient Assistance Program
866-435-5677
- Sutent (sunitinib malate) Capsules
- Pfizer
- Unresectable, locally advanced or metastatic pancreatic NETs
- Pfizer Oncology Together Co-Pay Savings Program
877-744-5675
Pfizer Patient Assistance Program
877-744-5675
- Welireg (belzutifan) Tablets
- Merck
- Treatment of adults with von Hippel-Lindau disease and pancreatic NETs not requiring immediate surgery
- Merck Co-Pay Coupon
855-257-3932
Merck Patient Assistance Program
855-257-3932